Diagnostic performance of LIVERFASt as a non-invasive liver fibrosis test: data from three cohorts (JGLD manuscript) easlfibronostg on June 29, 2026 Category: Publications Tag: Identification, LIVERFASt, MASLD, Screening Post navigation Previous: Previous post: Combination of LF and LSM using Fibroscan outperforms FIB-4 and LSM in patients with T2DNext: Next post: The utility of NITs — LIVERFASt, FIB-4 and VCTE — in the initiation and monitoring of Resmetirom therapy in MASH patients (initial cohort)
